Eton Pharmaceuticals (NASDAQ: ETON)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-15 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.080 | -0.210 | -0.1300 | ||||
REV | 7.100M | 2.176M | -4.924M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Eton Pharmaceuticals (NASDAQ: ETON) through any online brokerage.
Other companies in Eton Pharmaceuticals’s space includes: Opiant Pharma (NASDAQ:OPNT), SCYNEXIS (NASDAQ:SCYX), Terns Pharma (NASDAQ:TERN), Lipocine (NASDAQ:LPCN) and Longboard Pharmaceuticals (NASDAQ:LBPH).
The latest price target for Eton Pharmaceuticals (NASDAQ: ETON) was reported by HC Wainwright & Co. on Tuesday, March 22, 2022. The analyst firm set a price target for 11.00 expecting ETON to rise to within 12 months (a possible 313.53% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Eton Pharmaceuticals (NASDAQ: ETON) is $2.66 last updated July 6, 2022, 8:00 PM UTC.
There are no upcoming dividends for Eton Pharmaceuticals.
Eton Pharmaceuticals’s Q2 earnings are confirmed for Monday, August 15, 2022.
There is no upcoming split for Eton Pharmaceuticals.
Eton Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.